Evidence map›Paper›PMID 39391624›Full record

ArticleRSC advances2024

A novel porous interbody fusion cage modified by microarc oxidation and hydrothermal treatment technology accelerate osseointegration and spinal fusion in sheep.

Jiang Sun, Shan-Shan Liu, Da Zou, Ren-Hua Ni, Chong-Bin Wei, Hao Wang, Wei-Shi Li

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiang SunPeking University Third Hospital Beijing 100191 China sjdoctor@pku.edu.cn 1039165305@qq.com zd_puth@163.com tiffanyni@126.com puh3liweishi@163.com.
Shan-Shan LiuPeking University Third Hospital Beijing 100191 China sjdoctor@pku.edu.cn 1039165305@qq.com zd_puth@163.com tiffanyni@126.com puh3liweishi@163.com.
Da ZouPeking University Third Hospital Beijing 100191 China sjdoctor@pku.edu.cn 1039165305@qq.com zd_puth@163.com tiffanyni@126.com puh3liweishi@163.com.
Ren-Hua NiPeking University Third Hospital Beijing 100191 China sjdoctor@pku.edu.cn 1039165305@qq.com zd_puth@163.com tiffanyni@126.com puh3liweishi@163.com.
Chong-Bin WeiBeijing AKec Medical Co., Ltd Beijing 102200 China chongbin.wei@ak-medical.net hao.wang@ak-medical.net.
Hao WangBeijing AKec Medical Co., Ltd Beijing 102200 China chongbin.wei@ak-medical.net hao.wang@ak-medical.net.
Wei-Shi LiPeking University Third Hospital Beijing 100191 China sjdoctor@pku.edu.cn 1039165305@qq.com zd_puth@163.com tiffanyni@126.com puh3liweishi@163.com.ORCID https://orcid.org/0000-0001-9512-5436

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical outcome of spinal fusion surgery is closely related to the success of bone fusion. Nowadays, the interbody cage which is used to replace the disc for spinal fusion is expected to have biological activity to improve osseointegration, especially for the aging and osteoporotic patients. Here, through micro-arc oxidation and hydrothermal treatment (MAO + HT), a bioactive CaP coating with micro/nano multilevel morphology was developed on 3D printed Ti6Al4V alloy then verified

Identifiers

PMID39391624
PMCPMC11462409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.